Purchases and Sales Made in Q4 2023 in Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA) during Q4 2023. The information is specifically focused on institutions that hold shares of IOVANCE BIOTHERAPEUTICS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-357K- 27.62% |
$1.18M - $3.18M
|
937K
$2.19M
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-461K- 11.6% |
$1.52M - $4.1M
|
3.52M
$8.23M
|
|
Feb 14, 2024
Q4 2023
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-551K- 12.3% |
$1.82M - $4.9M
|
3.93M
$9.19M
|
|
Feb 14, 2024
Q4 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-658K- 41.01% |
$2.17M - $5.85M
|
946K
$2.21M
|
|
Feb 14, 2024
Q4 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-685K- 55.23% |
$2.26M - $6.09M
|
555K
$1.3M
|
|
Feb 14, 2024
Q4 2023
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-786K- 79.82% |
$2.59M - $6.99M
|
199K
$465K
|
|
Feb 14, 2024
Q4 2023
|
Brevan Howard Capital Management LP
St. Helier, Y9 |
SELL
|
- |
-789K- 53.24% |
$2.6M - $7.01M
|
693K
$1.62M
|
|
Feb 14, 2024
Q4 2023
|
Candriam S.C.A.
|
SELL
|
- |
-1.02M- 37.12% |
$3.37M - $9.07M
|
1.73M
$4.04M
|
|
Feb 13, 2024
Q4 2023
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-1.65M- 23.87% |
$5.45M - $14.7M
|
5.26M
$12.3M
|
|
Feb 14, 2024
Q4 2023
|
Boxer Capital, LLC
San Diego, CA |
SELL
|
- |
-2.31M- 62.21% |
$7.61M - $20.5M
|
1.4M
$3.28M
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-2.64M- 73.76% |
$8.72M - $23.5M
|
940K
$2.2M
|